Rating History for Relay Therapeutics (RLAY) by Oppenheimer

More Stocks Rated by Oppenheimer | Latest Ratings for RLAY
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/26/2026 Matt Biegler Upgrade Outperform
(Perform)		 14.00
(N/A)		 7.43
(9.89)		 33.11% Details